Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

9.25
-0.3100-3.24%
Post-market: 9.330.0800+0.86%19:30 EDT
Volume:3.59M
Turnover:33.62M
Market Cap:1.69B
PE:-90.68
High:9.69
Open:9.52
Low:9.18
Close:9.56
52wk High:11.33
52wk Low:5.25
Shares:182.32M
Float Shares:172.57M
Volume Ratio:0.59
T/O Rate:2.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1020
EPS(LYR):0.0032
ROE:-617.16%
ROA:6.13%
PB:-173.25
PE(LYR):2,884.32

Loading ...

Sep 28, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2026

Major Issues Report

Form 8-K - Current report
Aug 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2026

Major Issues Report

Form 8-K - Current report
Jul 31, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jul 17, 2026

Major Issues Report

Form 8-K - Current report
Jul 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 30, 2026

Major Issues Report

Form 8-K - Current report
Jun 11, 2026

Major Issues Report

Form 8-K - Current report
Jun 05, 2026

Major Issues Report

Form 8-K - Current report
Jun 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2026

Major Issues Report

Form 8-K - Current report